These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 20537838)

  • 1. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
    Derkx F; Maaskant-Braat AJ; van der Sangen MJ; Nieuwenhuijzen GA; van de Poll-Franse LV; Roumen RM; Voogd AC
    Eur J Surg Oncol; 2010 Jul; 36(7):646-51. PubMed ID: 20537838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
    Johnson J; Esserman L; Ewing C; Alvarado M; Park C; Fowble B
    Ann Surg Oncol; 2016 Mar; 23(3):715-21. PubMed ID: 26714943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study.
    Maaskant-Braat AJ; Roumen RM; Voogd AC; Pijpers R; Luiten EJ; Rutgers EJ; Nieuwenhuijzen GA
    Ann Surg Oncol; 2013 Feb; 20(2):620-6. PubMed ID: 22941173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile?
    Ugras S; Matsen C; Eaton A; Stempel M; Morrow M; Cody HS
    Ann Surg Oncol; 2016 Mar; 23(3):744-8. PubMed ID: 26644258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.
    Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Luiten EJ; Rutgers EJ; Rutten HJ; Roumen RM; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2015 Oct; 153(3):549-56. PubMed ID: 26358709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the Success Rate of Repeat Sentinel Node Biopsy in Recurrent Breast Cancer.
    Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Roumen RM; Luiten EJ; Rutgers EJ; Wyndaele D; Rutten HJ; Nieuwenhuijzen GA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S529-35. PubMed ID: 26259754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel Lymph Node Dissection in Locally Recurrent Breast Cancer.
    Uth CC; Christensen MH; Oldenbourg MH; Kjær C; Garne JP; Teilum D; Kroman N; Tvedskov TF
    Ann Surg Oncol; 2015 Aug; 22(8):2526-31. PubMed ID: 25564177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
    Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
    Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy.
    Gaines S; Suss N; Barrera E; Pesce C; Kuchta K; Winchester DJ; Yao K
    Ann Surg Oncol; 2018 Aug; 25(8):2220-2228. PubMed ID: 29626303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
    Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
    Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
    Soni NK; Spillane AJ
    ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.
    Olaya W; Wong J; Wong J; Morgan J; Kazanjian K; Lum S
    Ann Surg Oncol; 2013 Feb; 20(2):627-32. PubMed ID: 22956069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
    Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A
    Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.